144 related articles for article (PubMed ID: 23651474)
21. Effect of a new oral contraceptive with estradiol valerate/dienogest on carbohydrate metabolism.
De Leo V; Fruzzetti F; Musacchio MC; Scolaro V; Di Sabatino A; Morgante G
Contraception; 2013 Sep; 88(3):364-8. PubMed ID: 23769016
[TBL] [Abstract][Full Text] [Related]
22. Resistance to APC and SHBG levels during use of a four-phasic oral contraceptive containing dienogest and estradiol valerate: a randomized controlled trial.
Raps M; Rosendaal F; Ballieux B; Rosing J; Thomassen S; Helmerhorst F; van Vliet H
J Thromb Haemost; 2013 May; 11(5):855-61. PubMed ID: 23410231
[TBL] [Abstract][Full Text] [Related]
23. Unintended pregnancy rates differ according to combined oral contraceptive - results from the INAS-SCORE study.
Barnett C; Dinger J; Minh TD; Heinemann K
Eur J Contracept Reprod Health Care; 2019 Aug; 24(4):247-250. PubMed ID: 31204884
[No Abstract] [Full Text] [Related]
24. Effective treatment of heavy and/or prolonged menstrual bleeding without organic cause: pooled analysis of two multinational, randomised, double-blind, placebo-controlled trials of oestradiol valerate and dienogest.
Fraser IS; Parke S; Mellinger U; Machlitt A; Serrani M; Jensen J
Eur J Contracept Reprod Health Care; 2011 Aug; 16(4):258-69. PubMed ID: 21774563
[TBL] [Abstract][Full Text] [Related]
25. What role for Qlaira in contraception?
Drug Ther Bull; 2010 Sep; 48(9):102-5. PubMed ID: 20810709
[TBL] [Abstract][Full Text] [Related]
26. Treatment of heavy menstrual bleeding with the estradiol valerate and dienogest oral contraceptive pill.
Micks EA; Jensen JT
Adv Ther; 2013 Jan; 30(1):1-13. PubMed ID: 23239397
[TBL] [Abstract][Full Text] [Related]
27. Effect of extended-cycle regimen with an oral contraceptive containing 30 mcg ethinylestradiol and 2 mg dienogest on bleeding patterns, safety, acceptance and contraceptive efficacy.
Wiegratz I; Stahlberg S; Manthey T; Sänger N; Mittmann K; Lange E; Mellinger U; Palombo-Kinne E; Kuhl H
Contraception; 2011 Aug; 84(2):133-43. PubMed ID: 21757054
[TBL] [Abstract][Full Text] [Related]
28. Ovulation inhibition with four variations of a four-phasic estradiol valerate/dienogest combined oral contraceptive: results of two prospective, randomized, open-label studies.
Endrikat J; Parke S; Trummer D; Schmidt W; Duijkers I; Klipping C
Contraception; 2008 Sep; 78(3):218-25. PubMed ID: 18692612
[TBL] [Abstract][Full Text] [Related]
29. Impact of estradiol valerate/dienogest on work productivity and activities of daily living in women with heavy menstrual bleeding.
Wasiak R; Filonenko A; Vanness DJ; Law A; Jeddi M; Wittrup-Jensen KU; Stull DE; Siak S; Jensen JT
J Womens Health (Larchmt); 2013 Apr; 22(4):378-84. PubMed ID: 23586801
[TBL] [Abstract][Full Text] [Related]
30. Fertility and combined oral contraceptives - unintended pregnancies and planned pregnancies following oral contraceptive use - results from the INAS-SCORE study.
Barnett C; Hagemann C; Dinger J; Do Minh T; Heinemann K
Eur J Contracept Reprod Health Care; 2017 Feb; 22(1):17-23. PubMed ID: 27749101
[TBL] [Abstract][Full Text] [Related]
31. Contraception containing estradiol valerate and dienogest--advantages, adherence and user satisfaction.
Graziottin A
Minerva Ginecol; 2014 Oct; 66(5):479-95. PubMed ID: 25245997
[TBL] [Abstract][Full Text] [Related]
32. Estradiol valerate plus dienogest versus ethinylestradiol plus levonorgestrel for the treatment of primary dysmenorrhea.
Petraglia F; Parke S; Serrani M; Mellinger U; Römer T
Int J Gynaecol Obstet; 2014 Jun; 125(3):270-4. PubMed ID: 24713413
[TBL] [Abstract][Full Text] [Related]
33. Bleeding pattern and cycle control with estetrol-containing combined oral contraceptives: results from a phase II, randomised, dose-finding study (FIESTA).
Apter D; Zimmerman Y; Beekman L; Mawet M; Maillard C; Foidart JM; Coelingh Bennink HJ
Contraception; 2016 Oct; 94(4):366-73. PubMed ID: 27153745
[TBL] [Abstract][Full Text] [Related]
34. The shorter, the better: A review of the evidence for a shorter contraceptive hormone-free interval.
Graziottin A
Eur J Contracept Reprod Health Care; 2016; 21(2):93-105. PubMed ID: 26291185
[TBL] [Abstract][Full Text] [Related]
35. A comparison of two different oral contraceptives in patients with severe primary dysmenorrhoea.
Uysal G; Akkaya H; Cagli F; Tutus S; Tayyar AT
J Obstet Gynaecol; 2018 Aug; 38(6):828-832. PubMed ID: 29537325
[TBL] [Abstract][Full Text] [Related]
36. Efficacy and Safety of Estradiol Valerate/Dienogest for the Management of Heavy Menstrual Bleeding: A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Phase III Clinical Trial.
Yu Q; Zhou Y; Suturina L; Jaisamrarn U; Lu D; Parke S
J Womens Health (Larchmt); 2018 Oct; 27(10):1225-1232. PubMed ID: 29957101
[TBL] [Abstract][Full Text] [Related]
37. Novel oral contraceptive for heavy menstrual bleeding: estradiol valerate and dienogest.
Rafie S; Borgelt L; Koepf ER; Temple-Cooper ME; Lehman KJ
Int J Womens Health; 2013; 5():313-21. PubMed ID: 23788843
[TBL] [Abstract][Full Text] [Related]
38. Contraceptive efficacy and safety of estradiol valerate/dienogest in a healthy female population: a multicenter, open-label, uncontrolled Phase III study.
Yu Q; Huang Z; Ren M; Chang Q; Zhang Z; Parke S
Int J Womens Health; 2018; 10():257-266. PubMed ID: 29922096
[TBL] [Abstract][Full Text] [Related]
39. Estradiol valerate and dienogest: a novel four-phasic oral contraceptive pill effective for pregnancy prevention and treatment of heavy menstrual bleeding.
Micks E; Jensen JT
Womens Health (Lond); 2011 Sep; 7(5):513-24. PubMed ID: 21879819
[TBL] [Abstract][Full Text] [Related]
40. Efficacy of a combined oral contraceptive containing 0.030 mg ethinylestradiol/2 mg dienogest for the treatment of papulopustular acne in comparison with placebo and 0.035 mg ethinylestradiol/2 mg cyproterone acetate.
Palombo-Kinne E; Schellschmidt I; Schumacher U; Gräser T
Contraception; 2009 Apr; 79(4):282-9. PubMed ID: 19272497
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
